Using Patient-Reported Outcomes in Dose-Finding Oncology Trials: Surveys of Key Stakeholders and the National Cancer Research Institute Consumer Forum.

Julia Lai-KwonAlyssa M VanderbeekAnna MinchomOlalekan Lee AiyegbusiDella OgunleyeRichard StephensMelanie CalvertChristina Yap

Published in: The oncologist (2022)

Stakeholders reported minimal experience using PROs in DFOT but broadly supported their use. Guidelines are needed to standardize PRO selection, analysis, and reporting in DFOT.

Keyphrases

patient reported outcomes
clinical practice
cross sectional
health information
healthcare
anti inflammatory
emergency department
adverse drug